Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
König, T; Wurm, R; Parvizi, T; Silvaieh, S; Hotzy, C; Cetin, H; Klotz, S; Gelpi, E; Bancher, C; Benke, T; Dal-Bianco, P; Defrancesco, M; Fischer, P; Marksteiner, J; Sutterlüty, H; Ransmayr, G; Schmidt, R; Zimprich, A; Stögmann, E.
C9orf72 repeat length might influence clinical sub-phenotypes in dementia patients.
Neurobiol Dis. 2022; 175: 105927
Doi: 10.1016/j.nbd.2022.105927
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Schmidt Reinhold
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- BACKGROUND: C9orf72 repeat expansions have been observed in a wide variety of neurodegenerative disorders. The cut-off between normal and pathogenic alleles is not well established as repeat sizing methods are often semi-quantitative. However, intermediate alleles might influence disease prevalence and phenotype, as seen for other repeat expansion disorders. We aimed to further delineate the prevalence of small, intermediate and expanded C9orf72 alleles and elucidate their potential influence on the disease phenotype. METHODS: DNA derived from patients (n = 1804) and healthy individuals (n = 643) was obtained from multiple collectives in Austria. Genotyping was performed using a two-step PCR assay followed by Southern blotting. RESULTS: 3.4% of clinically diagnosed frontotemporal dementia (FTD; n = 5/147) cases and 0.8% of clinically diagnosed Alzheimer's disease (AD; n = 5/602) cases were carriers of a pathological C9orf72 repeat expansion. A significantly earlier disease onset was detected in expansion carriers compared to non-carriers in the FTD and AD cohorts (median 50 years, range 39-64 vs. median 64 years, range 36-92, p = 0.018 and median 63 years, range 54-71 vs. median 74 years, range 45-92, p = 0.006, respectively). C9orf72 intermediate alleles were significantly associated with cerebellar symptoms (p = 0.0004) and sensory deficits in the dementia cohort (p = 0.01). CONCLUSIONS: C9orf72 repeat expansion carriers showed earlier disease onset compared to non-carriers with clinical diagnosis of FTD and AD. Furthermore, C9orf72 intermediate repeats might modify the phenotypic expression in dementia.
- Find related publications in this database (using NLM MeSH Indexing)
- Humans - administration & dosage
- DNA Repeat Expansion - genetics
- C9orf72 Protein - genetics
- Frontotemporal Dementia - genetics, pathology
- Proteins - genetics
- Phenotype - administration & dosage
- Amyotrophic Lateral Sclerosis - genetics
- Find related publications in this database (Keywords)
- C9orf72 hexanucleotide repeat expansion
- Intermediate repeats
- Neurodegenerative diseases
- Alzheimer dementia (AD)
- Frontotemporal dementia (FTD)
- Early onset dementia
- Disease modifier